BOSTON--(BUSINESS WIRE)--Joslin Diabetes Center scientists are taking their groundbreaking research on the role of inflammation in type 2 diabetes to a new level this month with the launch of a national clinical trial to investigate whether salsalate, an anti-inflammatory drug used for years to manage arthritis pain, can reduce blood glucose levels in people with type 2 diabetes. If successful, the trial could lead one day to an inexpensive way to treat this most common form of diabetes, which has been increasing at epidemic rates in recent years.
